Want to see KVUE full AI Analyst Report?
KVUE Stock Chart & Stats
$17.61
-$0.04(-0.19%)
At close: 4:00 PM EST
$17.61
-$0.04(-0.19%)
Day’s Range― - ―
52-Week Range$14.02 - $22.87
Previous CloseN/A
Volume2.33M
Average Volume (3M)19.90M
Market Cap
$36.44B
Enterprise Value$41.40K
Total Cash (Recent Filing)$1.07B
Total Debt (Recent Filing)$8.66B
Price to Earnings (P/E)22.3
Beta0.01
Next Earnings
Aug 12, 2026EPS Estimate
0.32Next Dividend Ex-DateN/A
Dividend Yield4.85%
Share Statistics
EPS (TTM)0.85
Shares Outstanding1,920,008,700
10 Day Avg. Volume20,111,966
30 Day Avg. Volume19,898,311
Financial Highlights & Ratios
PEG Ratio0.52
Price to Book (P/B)3.06
Price to Sales (P/S)2.18
P/FCF Ratio19.14
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$19.20Price Target Upside9.03% Upside
Rating ConsensusHold
Number of Analyst Covering6
EPS Forecast (FY)1.2
Revenue Forecast (FY)$15.64B
Bulls Say, Bears Say
Bulls Say
Brand Portfolio & Market ReachA diversified portfolio of established consumer brands and multi‑channel distribution creates durable demand, shelf presence and pricing leverage. These structural advantages support steady unit volumes, reduce single-category risk, and sustain revenue resilience through economic cycles.
High Margins And Strong FCFSustained high gross margins and robust free cash flow conversion indicate the business converts earnings into cash effectively. This durable cash generation underpins dividends, working capital, reinvestment, and debt servicing, enhancing strategic flexibility over the medium term.
Governance & Management ContinuityClear shareholder support for the board, executive compensation and auditor signals stable governance and management continuity. Reduced leadership turnover lowers execution risk and supports consistent long-term strategy implementation and financial oversight.
Bears Say
Low Organic Revenue GrowthA low growth profile limits structural upside; with revenue effectively flat, future earnings expansion will depend more on pricing, mix or cost cuts than on meaningful organic demand growth. That constrains scalability and investor return drivers over the medium term.
Elevated Financial LeverageModerate-to-elevated leverage reduces financial flexibility and raises sensitivity to interest rate moves. Higher debt levels can limit capacity for bolt-on M&A, larger capital projects or aggressive buybacks, and increase refinancing risk in adverse market conditions.
Volatile Margins And Cash FlowChoppy profitability and cash flow history undermine predictability of earnings and free cash flow. This structural volatility complicates planning, raises the likelihood of cyclical stress during slower demand, and may constrain consistent reinvestment or dividend certainty.
Kenvue, Inc. News
KVUE FAQ
What was Kenvue, Inc.’s price range in the past 12 months?
Kenvue, Inc. lowest stock price was $14.02 and its highest was $22.87 in the past 12 months.
What is Kenvue, Inc.’s market cap?
Kenvue, Inc.’s market cap is $36.44B.
When is Kenvue, Inc.’s upcoming earnings report date?
Kenvue, Inc.’s upcoming earnings report date is Aug 12, 2026 which is in 23 days.
How were Kenvue, Inc.’s earnings last quarter?
Kenvue, Inc. released its earnings results on May 07, 2026. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.262 by $0.058.
Is Kenvue, Inc. overvalued?
According to Wall Street analysts Kenvue, Inc.’s price is currently Undervalued.
Does Kenvue, Inc. pay dividends?
Kenvue, Inc. pays a Quarterly dividend of $0.207 which represents an annual dividend yield of 4.85%. See more information on Kenvue, Inc. dividends here
What is Kenvue, Inc.’s EPS estimate?
Kenvue, Inc.’s EPS estimate is 0.32.
How many shares outstanding does Kenvue, Inc. have?
Kenvue, Inc. has 1,920,008,700 shares outstanding.
What happened to Kenvue, Inc.’s price movement after its last earnings report?
Kenvue, Inc. reported an EPS of $0.32 in its last earnings report, beating expectations of $0.262. Following the earnings report the stock price went up 0.223%.
Which hedge fund is a major shareholder of Kenvue, Inc.?
Currently, no hedge funds are holding shares in KVUE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Kenvue, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$19.20 (9.03% Upside)
$19.20 (9.03% Upside)
Blogger Sentiment
Bullish
KVUE Sentiment 70%
Sector Average 63%
Sector Average 63%
Hedge Fund Trend
Increased
By 19.0M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $746.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days >0.1%
Last 30 Days ▲ 4.3%
Last 30 Days ▲ 4.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-9.10%
12-Months-Change
Fundamentals
Return on Equity
15.18%
Trailing 12-Months
Asset Growth
2.27%
Trailing 12-Months
Company Description
Kenvue, Inc.
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
KVUE Revenue Breakdown
42.17% Self Care
27.20% Skin Health and Beauty
30.63% Essential Health
KVUE Stock 12 Month Forecast
Average Price Target
$19.20
▲(9.03% Upside)
Technical Analysis
Ownership Overview
1.45% Insiders
24.22% Mutual Funds
0.37% Other Institutional Investors
44.38% Public Companies and Individual Investors